These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 1797567
1. CCK-8-related C-terminal tetrapeptides: affinities for central CCKB and peripheral CCKA receptors. Harhammer R, Schäfer U, Henklein P, Ott T, Repke H. Eur J Pharmacol; 1991 Dec 17; 209(3):263-6. PubMed ID: 1797567 [Abstract] [Full Text] [Related]
2. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives. Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP. J Med Chem; 1993 Jan 08; 36(1):166-72. PubMed ID: 8421283 [Abstract] [Full Text] [Related]
3. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors. Charpentier B, Dor A, Roy P, England P, Pham H, Durieux C, Roques BP. J Med Chem; 1989 Jun 08; 32(6):1184-90. PubMed ID: 2724293 [Abstract] [Full Text] [Related]
10. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes. Galas MC, Bernad N, Martinez J. Eur J Pharmacol; 1992 May 12; 226(1):35-41. PubMed ID: 1327841 [Abstract] [Full Text] [Related]
11. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice. Hernando F, Fuentes JA, Roques BP, Ruiz-Gayo M. Eur J Pharmacol; 1994 Aug 22; 261(3):257-63. PubMed ID: 7813546 [Abstract] [Full Text] [Related]
12. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line. Lignon MF, Bernad N, Martinez J. Eur J Pharmacol; 1993 May 15; 245(3):241-6. PubMed ID: 8335062 [Abstract] [Full Text] [Related]
13. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Corp ES, McQuade J, Moran TH, Smith GP. Brain Res; 1993 Sep 24; 623(1):161-6. PubMed ID: 8221086 [Abstract] [Full Text] [Related]
15. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models. Ballaz S, Barber A, Fortuño A, Del Río J, Martin-Martínez M, Gómez-Monterrey I, Herranz R, González-Muñiz R, García-López MT. Br J Pharmacol; 1997 Jun 24; 121(4):759-67. PubMed ID: 9208145 [Abstract] [Full Text] [Related]
16. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists. Gonzalez-Muniz R, Bergeron F, Marseigne I, Durieux C, Roques BP. J Med Chem; 1990 Dec 24; 33(12):3199-204. PubMed ID: 1701834 [Abstract] [Full Text] [Related]
17. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity. Jagerschmidt A, Guillaume-Rousselet N, Vikland ML, Goudreau N, Maigret B, Roques BP. Eur J Pharmacol; 1996 Jan 18; 296(1):97-106. PubMed ID: 8720482 [Abstract] [Full Text] [Related]
18. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization. Saita Y, Yazawa H, Honma Y, Nishida A, Miyata K, Honda K. Eur J Pharmacol; 1994 Oct 14; 269(2):249-54. PubMed ID: 7851501 [Abstract] [Full Text] [Related]
19. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. Gully D, Fréhel D, Marcy C, Spinazzé A, Lespy L, Neliat G, Maffrand JP, Le Fur G. Eur J Pharmacol; 1993 Feb 23; 232(1):13-9. PubMed ID: 7681406 [Abstract] [Full Text] [Related]
20. CCKB receptor activation results in increased [3H]thymidine incorporation in rat glioma C6 cells. Kaufmann R, Henklein P, Nowak G. Neuropeptides; 1995 Nov 23; 29(5):241-4. PubMed ID: 8587658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]